Kindred Biosciences Announces Third Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street dips as higher yields, rising oil prices mark shaky start to SeptemberÂ
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- The Warsh pivot markets didn't expect
Kindred Biosciences (KIN) Misses Q3 EPS by 2c
November 12, 2019 4:29 PM ESTKindred Biosciences (NASDAQ: KIN) reported Q3 EPS of ($0.39), $0.02 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $1.1 million versus the consensus estimate of $1.66 million.
For earnings history and earnings-related data on Kindred Biosciences (KIN) click here.
... More